Skip to main content
. 2002 Oct;130(1):49–58. doi: 10.1046/j.1365-2249.2002.t01-1-01935.x

Fig. 6.

Fig. 6

IgE immunoblots revealed with a pooled serum obtained from CMA patients. Lane 1: CM immunoblotting under reducing conditions, lane 2: soybean immunoblotting (under non reducing conditions), lane 3: S30 immunoblotting under nonreducing conditions, lane 4: S30 immunoblotting under reducing conditions.